Immunogenicity of Extended mRNA SARS-CoV-2 Vaccine Dosing Intervals

被引：50
作者：
Grunau, Brian [1 ]
Goldfarb, DavidM. [2 ]
Asamoah-Boaheng, Michael [3 ]
Golding, Liam [4 ]
Kirkham, Tracy L. [5 ]
Demers, Paul A. [5 ]
Lavoie, Pascal M. [6 ]
机构：
[1] Univ British Columbia, Dept Emergency Med, Vancouver, BC, Canada
[2] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC, Canada
[3] Mem Univ Newfoundland, Fac Med, St John, NF, Canada
[4] Univ British Columbia, Dept Obstet & Gynecol, Vancouver, BC, Canada
[5] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada
[6] Univ British Columbia, Dept Pediat, Vancouver, BC, Canada
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2022年 / 327卷 / 03期
关键词：
D O I：
10.1001/jama.2021.21921
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：279 / 281
页数：3
相关论文
共 6 条
  • [1] cdc, About COVID-19
  • [2] Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
    Khoury, David S.
    Cromer, Deborah
    Reynaldi, Arnold
    Schlub, Timothy E.
    Wheatley, Adam K.
    Juno, Jennifer A.
    Subbarao, Kanta
    Kent, Stephen J.
    Triccas, James A.
    Davenport, Miles P.
    [J]. NATURE MEDICINE, 2021, 27 (07) : 1205 - +
  • [3] Evaluation of COVID-19 vaccination strategies with a delayed second dose
    Moghadas, Seyed M.
    Vilches, Thomas N.
    Zhang, Kevin
    Nourbakhsh, Shokoofeh
    Sah, Pratha
    Fitzpatrick, Meagan C.
    Galvani, Alison P.
    [J]. PLOS BIOLOGY, 2021, 19 (04)
  • [4] Public health impact of delaying second dose of BNT162b2 or mRNA-1273 covid-19 vaccine: simulation agent based modeling study
    Romero-Brufau, Santiago
    Chopra, Ayush
    Ryu, Alex J.
    Gel, Esma
    Raskar, Ramesh
    Kremers, Walter
    Anderson, Karen S.
    Subramanian, Jayakumar
    Krishnamurthy, Balaji
    Singh, Abhishek
    Pasupathy, Kalyan
    Dong, Yue
    O'Horo, John C.
    Wilson, Walter R.
    Mitchell, Oscar
    Kingsley, Thomas C.
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2021, 373
  • [5] Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials
    Voysey, Merryn
    Clemens, Sue Ann Costa
    Madhi, Shabir A.
    Weckx, Lily Y.
    Folegatti, Pedro M.
    Aley, Parvinder K.
    Angus, Brian
    Baillie, Vicky L.
    Barnabas, Shaun L.
    Bhorat, Qasim E.
    Bibi, Sagida
    Briner, Carmen
    Cicconi, Paola
    Clutterbuck, Elizabeth A.
    Collins, Andrea M.
    Cutland, Clare L.
    Darton, Thomas C.
    Dheda, Keertan
    Dold, Christina
    Duncan, Christopher J. A.
    Emary, Katherine R. W.
    Ewer, Katie J.
    Flaxman, Amy
    Fairlie, Lee
    Faust, Saul N.
    Feng, Shuo
    Ferreira, Daniela M.
    Finn, Adam
    Galiza, Eva
    Goodman, Anna L.
    Green, Catherine M.
    Green, Christopher A.
    Greenland, Melanie
    Hill, Catherine
    Hill, Helen C.
    Hirsch, Ian
    Izu, Alane
    Jenkin, Daniel
    Joe, Carina C. D.
    Kerridge, Simon
    Koen, Anthonet
    Kwatra, Gaurav
    Lazarus, Rajeka
    Libri, Vincenzo
    Lillie, Patrick J.
    Marchevsky, Natalie G.
    Marshall, Richard P.
    Mendes, Ana V. A.
    Milan, Eveline P.
    Minassian, Angela M.
    [J]. LANCET, 2021, 397 (10277) : 881 - 891
  • [6] HEPATITIS-B VACCINATION WITH SHORT DOSE INTERVALS - A POSSIBLE ALTERNATIVE FOR POST-EXPOSURE PROPHYLAXIS
    WAHL, M
    HERMODSSON, S
    IWARSON, S
    [J]. INFECTION, 1988, 16 (04) : 229 - 232
1